Although new classification criteria of NMO/NMO-SD have been published very recently, which uses a unifying terminology of NMO-SD with or without AQP4 antibodies[21], in this paper we still use the widely accepted NMO/NMO-SD definition since patients were diagnosed based on the 2006 criteria[3]. Here, AQP4 is linked to Salla disease.